Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Neuroglialpharmacology: white matter pathophysiologies and psychiatric treatments.

Bartzokis G.

Front Biosci (Landmark Ed). 2011 Jun 1;16:2695-733. Review.

PMID:
21622204
[PubMed - indexed for MEDLINE]
2.

Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.

Bartzokis G.

Neuropharmacology. 2012 Jun;62(7):2137-53. doi: 10.1016/j.neuropharm.2012.01.015. Epub 2012 Jan 28. Review.

PMID:
22306524
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Convergence and divergence in the etiology of myelin impairment in psychiatric disorders and drug addiction.

Feng Y.

Neurochem Res. 2008 Oct;33(10):1940-9. doi: 10.1007/s11064-008-9693-x. Epub 2008 Apr 11. Review.

PMID:
18404371
[PubMed - indexed for MEDLINE]
4.

Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.

Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S.

Lancet. 2003 Sep 6;362(9386):798-805.

PMID:
13678875
[PubMed - indexed for MEDLINE]
5.

Epigenetics of psychoactive drugs.

Boyadjieva N, Varadinova M.

J Pharm Pharmacol. 2012 Oct;64(10):1349-58. doi: 10.1111/j.2042-7158.2012.01475.x. Epub 2012 Apr 8. Review.

PMID:
22943166
[PubMed - indexed for MEDLINE]
6.

Epigenetic marking and neuronal plasticity.

Duman RS, Newton SS.

Biol Psychiatry. 2007 Jul 1;62(1):1-3. Review. No abstract available.

PMID:
17572174
[PubMed - indexed for MEDLINE]
7.

White matter changes in schizophrenia: evidence for myelin-related dysfunction.

Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, Buxbaum J, Haroutunian V.

Arch Gen Psychiatry. 2003 May;60(5):443-56. Review.

PMID:
12742865
[PubMed - indexed for MEDLINE]
8.

Acetylcholinesterase inhibitors may improve myelin integrity.

Bartzokis G.

Biol Psychiatry. 2007 Aug 15;62(4):294-301. Epub 2006 Oct 27. Review.

PMID:
17070782
[PubMed - indexed for MEDLINE]
9.

Sphingolipid abnormalities in psychiatric disorders: a missing link in pathology?

Narayan S, Thomas EA.

Front Biosci (Landmark Ed). 2011 Jan 1;16:1797-810. Review.

PMID:
21196265
[PubMed - indexed for MEDLINE]
10.

Annual Research Review: New frontiers in developmental neuropharmacology: can long-term therapeutic effects of drugs be optimized through carefully timed early intervention?

Andersen SL, Navalta CP.

J Child Psychol Psychiatry. 2011 Apr;52(4):476-503. doi: 10.1111/j.1469-7610.2011.02376.x. Epub 2011 Feb 10. Review.

PMID:
21309771
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Improving myelin/oligodendrocyte-related dysfunction: a new mechanism of antipsychotics in the treatment of schizophrenia?

Ren Y, Wang H, Xiao L.

Int J Neuropsychopharmacol. 2013 Apr;16(3):691-700. doi: 10.1017/S1461145712001095. Epub 2012 Nov 20. Review.

PMID:
23164411
[PubMed - indexed for MEDLINE]
12.

Molecular psychiatry. Adaptations of receptor-coupled signal transduction pathways underlying stress- and drug-induced neural plasticity.

Duman RS, Heninger GR, Nestler EJ.

J Nerv Ment Dis. 1994 Dec;182(12):692-700. Review.

PMID:
7989913
[PubMed - indexed for MEDLINE]
13.

[Review of psychopharmacological treatments in adolescents and adults with autistic disorders].

Baghdadli A, Gonnier V, Aussilloux C.

Encephale. 2002 May-Jun;28(3 Pt 1):248-54. Review. French.

PMID:
12091786
[PubMed - indexed for MEDLINE]
14.

Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia.

Takahashi N, Sakurai T, Davis KL, Buxbaum JD.

Prog Neurobiol. 2011 Jan;93(1):13-24. doi: 10.1016/j.pneurobio.2010.09.004. Epub 2010 Oct 13. Review.

PMID:
20950668
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].

Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly.

Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. French.

PMID:
19748369
[PubMed - indexed for MEDLINE]
16.

Myelination and oligodendrocyte functions in psychiatric diseases.

Nave KA, Ehrenreich H.

JAMA Psychiatry. 2014 May;71(5):582-4. doi: 10.1001/jamapsychiatry.2014.189. Review. No abstract available.

PMID:
24671770
[PubMed - indexed for MEDLINE]
17.

Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease.

Bartzokis G.

Neurobiol Aging. 2004 Jan;25(1):5-18; author reply 49-62. Review.

PMID:
14675724
[PubMed - indexed for MEDLINE]
18.

Neurotransmitter-mediated regulation of CNS myelination: a review.

Belachew S, Rogister B, Rigo JM, Malgrange B, Moonen G.

Acta Neurol Belg. 1999 Mar;99(1):21-31. Review.

PMID:
10218089
[PubMed - indexed for MEDLINE]
19.

Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism.

Misra M, Papakostas GI, Klibanski A.

J Clin Psychiatry. 2004 Dec;65(12):1607-18; quiz 1590, 1760-1. Review.

PMID:
15641865
[PubMed - indexed for MEDLINE]
20.

Quantifying age-related myelin breakdown with MRI: novel therapeutic targets for preventing cognitive decline and Alzheimer's disease.

Bartzokis G, Lu PH, Mintz J.

J Alzheimers Dis. 2004 Dec;6(6 Suppl):S53-9.

PMID:
15665415
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk